Wenyu Li

机构：Wenzhou Medical University, First Affiliated Hospital of Wenzhou Medical University, International Peace Maternity & Child Health Hospital · ORCID：0000-0002-6444-7149

发表论文 176 篇 · 总被引 1928 次 · h-index 22

代表论文

• Anxiety about artificial intelligence from patient and doctor-physician (2024 · Patient Education and Counseling · 被引 31)
• Epcoritamab, lenalidomide, and rituximab versus lenalidomide and rituximab for relapsed or refractory follicular lymphoma (EPCORE FL-1): a global, open-label, randomised, phase 3 trial (2025 · The Lancet · 被引 19)
• Full polarization and high coherence control of thermal emissions via saddle-band dispersion engineering (2025 · Nature Communications · 被引 14)
• Development of chimeric Nanobody-Granzyme B functionalized ferritin nanoparticles for precise tumor therapy (2025 · Pharmacological Research · 被引 11)
• Comparison of zuberitamab plus CHOP versus rituximab plus CHOP for the treatment of drug-naïve patients diagnosed with CD20-positive diffuse large B-cell lymphoma: a phase 3 trial (2024 · Journal for ImmunoTherapy of Cancer · 被引 6)
• Phase 2 study of relmacabtagene autoleucel (CD19 CAR-T) for relapsed/refractory mantle cell lymphoma in Chinese adults (2025 · Blood Advances · 被引 5)